OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PCVX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Vaxcyte (PCVX) Earnings Date & Reports

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PCVX is expected to report earnings to fall 2.46% to -119 cents per share on November 10

Q3'25

Est.

$-1.19

Q2'25

Missed

by $0.05

Q1'25

Est.

$-1.04

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.27

The last earnings report on August 06 showed earnings per share of -122 cents, missing the estimate of -116 cents. With 141.24K shares outstanding, the current market capitalization sits at 3.88B.

View a ticker or compare two or three

Compare

PCVX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PCVX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PCVX showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a company which engages in development of vaccines for infectious diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

825 Industrial Road

Phone

+1 650 837-0111

Employees

254

Web

https://www.vaxcyte.com